Zion Market Research has published a new report titled “Newborn Screening Market by Product (Instruments and Assay Kits and Reagents), by Screening Test (Dry Blood Spot Test, Critical Congenital Heart Disease, Hearing Screen, Urine Test, and Other Tests), and by End-User (Hospitals, Clinics, and Diagnostic Centers): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global newborn screening market was approximately USD 739 million in 2018 and is expected to generate around USD 1,584 million by 2025, at a CAGR of around 11.5% between 2019 and 2025.
Request For PDF Research Report Brochure @ www.zionmarketresearch.com/requestbrochure/newborn-screening-market
The growing base of neonatal population, increasing cases of congenital diseases, favorable government policies, and technological advancements are likely to aid the global newborn screening market growth. World population meter reported more than 88 billion babies were born in 2015, i.e., around 250 births every minute. Out of these, more than 2.8 million newborns died within a few months of their birth due to the absence of screening and skilled childcare. Thus, to prevent this number from rising, efforts are being made by organizations like CDC, WHO, Healthy Newborn Network, etc., to educate parents about possible diagnostic procedures and birth disorders. The demand for these screening procedures is likely to be influenced by the growing paranoia of parents, the introduction of new screening technologies, and convenience of new treatment options that enable the diagnosis of more than 29 possible disorders, such as galactosemia (GS), phenylketonuria (PKU), hearing disorders, etc.
By product, the market for newborn screening is divided into instruments and assay kits and reagents. The instruments segment is further classified into pulse oximeter, mass spectrometer, hearing screening devices, laparoscopes, retinoscopes, ultrasound machines, and others. Mass spectrometers are likely to hold major market share in the future, owing to their increased function in diagnosing various conditions in a single procedure. Federal agencies are promoting mandatory testing of 50 conditions, which can be easily screened via mass spectrometers.
Get Sample Report of Newborn Screening Market @ www.zionmarketresearch.com/sample/newborn-screening-market
On the basis of the screening test, the newborn screening market is fragmented into critical congenital heart disease, dry blood spot test, hearing screen, urine test, and other tests. The dry blood spot test is likely to showcase a high growth rate in the years ahead. The blood collected from a newborn’s heel within 48 hours of birth on the screening card for diagnosis of more than 50 conditions is termed as dried blood spot test (DBS) or heel stick. Lymphomas, autism, leukemia, and other metabolic conditions can be analyzed through this test. The card used for this test is provided free of cost in North America, under the plan to promote higher procedural volume.
Based on end-user, the newborn screening market is divided into hospitals, clinics, and diagnostic centers. Hospitals dominated the market, in terms of revenue, in 2018. Investments made by private sectors in newborn screening programs and growing partnerships of private investors with diagnostic centers and hospitals are likely to offer new growth opportunities for newborn screening market in developing countries with a large population base.
North America dominated the global newborn screening market in 2018, due to enforced testing and increasing prevalence of congenital disorders in 50 regional states. Newborn screening program and tests are thoroughly followed in all the North American states. As per the CDC, in 2014, around four million babies annually are screened for various congenital conditions.
For more information Visit@ www.zionmarketresearch.com/inquiry/newborn-screening-market
Some leading players operating in the global newborn screening market are Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific, Agilent Technologies, ZenTech, Trivitron Healthcare, PerkinElmer, Natus Medical, MP Biomedicals, and Medtronic.
This report segments the global newborn screening market into:
Global Newborn Screening Market: By Product
- Pulse Oximeter
- Mass Spectrometer
- Hearing Screening Devices
- Ultrasound Machines
- Assay Kits and Reagents
Global Newborn Screening Market: By Screening Test
- Dry Blood Spot Test
- Critical Congenital Heart Disease (CCHD)
- Hearing Screen
- Urine Test
- Other Tests
Global Newborn Screening Market: By end-user
- Diagnostic Centers